Cargando…
Carbon ion radiotherapy in a hypofractionation regimen for stage I non-small-cell lung cancer
Introduction: In 1994, we started carbon-ion radiotherapy (CIRT) for peripheral stage I non-small-cell lung cancer (NSCLC). First, two phase I/II clinical trials demonstrated the optimal doses of 90.0 GyE in 18 fractions over 6 weeks (Protocol 9303) and 72.0 GyE in 9 fractions over 3 weeks (Protocol...
Autores principales: | Takahashi, Wataru, Nakajima, Mio, Yamamoto, Naoyoshi, Tsuji, Hiroshi, Kamada, Tadashi, Tsujii, Hirohiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3941516/ http://dx.doi.org/10.1093/jrr/rrt216 |
Ejemplares similares
-
Up-to-date results of carbon-ion radiotherapy for prostate cancer
por: Nomiya, Takuma, et al.
Publicado: (2014) -
Experience of long-term management for osteoradionecrosis of the maxilla after carbon ion radiotherapy
por: Ikawa, Hiroaki, et al.
Publicado: (2014) -
Carbon Ion Radiotherapy for Oligo-Recurrence in the Lung
por: Yamamoto, Naoyoshi, et al.
Publicado: (2013) -
Carbon ion radiotherapy for oligo-recurrent lung metastases from colorectal cancer: a feasibility study
por: Takahashi, Wataru, et al.
Publicado: (2014) -
Development of a compact superconducting rotating-gantry for heavy-ion therapy
por: Iwata, Yoshiyuki, et al.
Publicado: (2014)